Welcome to the World of FSHD Research
The mission of the NIH-supported University of Massachusetts Medical School Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center for FSHD is to further our understanding of the underlying molecular and cellular pathology of facioscapulohumeral muscular dystrophy (FSHD) and to develop therapeutics for treatment of this devastating disease. The Center has established a large repository of FSHD muscle tissue and cells and a disease biomarker database as unique resources for FSHD research and evaluation of outcomes of FSHD clinical trials. The Center is led by Dr. Charles P. Emerson at the University of Massachusetts Medical School, and Dr. Louis Kunkel at Children's Hospital Boston and Harvard Medical School, who lead a collaborative team of basic and clinical investigators with laboratories at Kennedy Krieger Institute, Johns Hopkins School of Medicine, University of Massachusetts Medical School, University of Maryland School of Medicine, and the University of Texas Southwestern Medical Center. The Center partners with the FSH Society for patient outreach activities and with biotechnology companies for development of therapeutics. The goal of our Wellstone Center is to translate basic discoveries on FSHD disease mechanisms into the clinic through therapeutic development.
Celebration of a Clinic and Research Center at UMMS - November 16, 2013
To Serve the FSHD Patient Community in the Northeast
UMMS-UMMHC FSH Muscular Dystrophy Clinic - Opens November 2013
FSHD Muscle Cell Distribution